BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

729 related articles for article (PubMed ID: 12704388)

  • 1. Constitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosis.
    Nicolas G; Viatte L; Lou DQ; Bennoun M; Beaumont C; Kahn A; Andrews NC; Vaulont S
    Nat Genet; 2003 May; 34(1):97-101. PubMed ID: 12704388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory defects in liver and intestine implicate abnormal hepcidin and Cybrd1 expression in mouse hemochromatosis.
    Muckenthaler M; Roy CN; Custodio AO; Miñana B; deGraaf J; Montross LK; Andrews NC; Hentze MW
    Nat Genet; 2003 May; 34(1):102-7. PubMed ID: 12704390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron stores modulate hepatic hepcidin expression by an HFE-independent pathway.
    Gehrke SG; Herrmann T; Kulaksiz H; Merle U; Bents K; Kaiser I; Riedel HD; Stremmel W
    Digestion; 2005; 72(1):25-32. PubMed ID: 16103673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis.
    Bridle KR; Frazer DM; Wilkins SJ; Dixon JL; Purdie DM; Crawford DH; Subramaniam VN; Powell LW; Anderson GJ; Ramm GA
    Lancet; 2003 Feb; 361(9358):669-73. PubMed ID: 12606179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disruption of hemochromatosis protein and transferrin receptor 2 causes iron-induced liver injury in mice.
    Delima RD; Chua AC; Tirnitz-Parker JE; Gan EK; Croft KD; Graham RM; Olynyk JK; Trinder D
    Hepatology; 2012 Aug; 56(2):585-93. PubMed ID: 22383097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-HFE hemochromatosis.
    Pietrangelo A
    Semin Liver Dis; 2005 Nov; 25(4):450-60. PubMed ID: 16315138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of alcohol consumption on iron metabolism in mice with hemochromatosis mutations.
    Flanagan JM; Peng H; Beutler E
    Alcohol Clin Exp Res; 2007 Jan; 31(1):138-43. PubMed ID: 17207112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Digenic inheritance of mutations in HAMP and HFE results in different types of haemochromatosis.
    Merryweather-Clarke AT; Cadet E; Bomford A; Capron D; Viprakasit V; Miller A; McHugh PJ; Chapman RW; Pointon JJ; Wimhurst VL; Livesey KJ; Tanphaichitr V; Rochette J; Robson KJ
    Hum Mol Genet; 2003 Sep; 12(17):2241-7. PubMed ID: 12915468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in HAMP and HJV genes and their impact on expression of clinical hemochromatosis in a cohort of 100 Spanish patients homozygous for the C282Y mutation of HFE gene.
    Altès A; Bach V; Ruiz A; Esteve A; Felez J; Remacha AF; Sardà MP; Baiget M
    Ann Hematol; 2009 Oct; 88(10):951-5. PubMed ID: 19214511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Non-HFE-related hereditary iron overload].
    Aguilar-Martinez P
    Presse Med; 2007 Sep; 36(9 Pt 2):1279-91. PubMed ID: 17540536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepcidin, a candidate modifier of the hemochromatosis phenotype in mice.
    Nicolas G; Andrews NC; Kahn A; Vaulont S
    Blood; 2004 Apr; 103(7):2841-3. PubMed ID: 14656876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [HFE hemochromatosis: pathogenic and diagnostic approach].
    Brissot P; Le Lan C; Troadec MB; Lorho R; Ropert M; Lescoat G; Loréal O
    Transfus Clin Biol; 2005 Jun; 12(2):77-82. PubMed ID: 15925529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pathophysiology and genetics of classic HFE (type 1) hemochromatosis].
    Loréal O; Ropert M; Mosser A; Déhais V; Deugnier Y; David V; Brissot P; Jouanolle AM
    Presse Med; 2007 Sep; 36(9 Pt 2):1271-7. PubMed ID: 17521857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The transferrin receptor modulates Hfe-dependent regulation of hepcidin expression.
    Schmidt PJ; Toran PT; Giannetti AM; Bjorkman PJ; Andrews NC
    Cell Metab; 2008 Mar; 7(3):205-14. PubMed ID: 18316026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone morphogenetic protein signaling is impaired in an HFE knockout mouse model of hemochromatosis.
    Corradini E; Garuti C; Montosi G; Ventura P; Andriopoulos B; Lin HY; Pietrangelo A; Babitt JL
    Gastroenterology; 2009 Oct; 137(4):1489-97. PubMed ID: 19591830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective role of calreticulin in HFE hemochromatosis.
    Pinto JP; Ramos P; de Almeida SF; Oliveira S; Breda L; Michalak M; Porto G; Rivella S; de Sousa M
    Free Radic Biol Med; 2008 Jan; 44(1):99-108. PubMed ID: 18045552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemochromatosis and pregnancy: iron stores in the Hfe-/- mouse are not reduced by multiple pregnancies.
    Neves JV; Olsson IA; Porto G; Rodrigues PN
    Am J Physiol Gastrointest Liver Physiol; 2010 Apr; 298(4):G525-9. PubMed ID: 20110460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iron-independent specific protein expression pattern in the liver of HFE-deficient mice.
    Petrak J; Myslivcova D; Halada P; Cmejla R; Cmejlova J; Vyoral D; Vulpe CD
    Int J Biochem Cell Biol; 2007; 39(5):1006-15. PubMed ID: 17376729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined deletion of Hfe and transferrin receptor 2 in mice leads to marked dysregulation of hepcidin and iron overload.
    Wallace DF; Summerville L; Crampton EM; Frazer DM; Anderson GJ; Subramaniam VN
    Hepatology; 2009 Dec; 50(6):1992-2000. PubMed ID: 19824072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of new mutations of the HFE, hepcidin, and transferrin receptor 2 genes by denaturing HPLC analysis of individuals with biochemical indications of iron overload.
    Biasiotto G; Belloli S; Ruggeri G; Zanella I; Gerardi G; Corrado M; Gobbi E; Albertini A; Arosio P
    Clin Chem; 2003 Dec; 49(12):1981-8. PubMed ID: 14633868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.